Abstract
Purpose: To determine the effects of amifostine on an isolated perfused rat-heart model and its protective activity with regard to cardiotoxic doxorubicin perfusion. Methods: Langendorff constant-pressure isolated rat-heart preparations were used to analyze the effects of the drugs during a 40-min period of perfusion after a 20-min stabilization interval. The first study was conducted with amifostine alone (controls and 10−6, 10−5, and 10−4 M amifostine; n=6 in each group). The second study was conducted with amifostine and doxorubicin (controls, 2.5 × 10−5 M doxorubicin, 2.5 × 10−5 M doxorubicin and 10−5 M amifostine, and 2.5 × 10−5 M doxorubicin and 10−4 M amifostine; n=4 in each group). Results: Amifostine had no significant effect on hemodynamic parameters at 10−6, 10−5, and 10−4 M concentrations. However, amifostine increased the coronary flow expressed as a percentage ± SEM of the baseline flow as follows: 82 ± 4% for controls, 95 ± 6% for 10−6 M amifostine, (P=0.13), 111 ± 4% for 10−5 M amifostine (P < 0.01), and 104 ± 3% for 10−6 M amifostine (P < 0.01). When we commenced an amifostine perfusion 20 min in advance of and then during a 40-min perfusion with doxorubicin, at a cardiotoxic concentration of 2.5 × 10−5 M the left ventricular pressures (LVDP, expressed as percentages ± SEM of the baseline LVDP before doxorubicin) were 55 ± 3% for the doxorubicin controls, 68 ± 2% for doxorubicin with 10−5 M amifostine (P=0.05), and 80 ± 3% for doxorubicin with 10−4 M amifostine (P < 0.01). Whether this protective effect might be related to the known free-radical-scavenging activity of amifostine remains to be determined. Conclusion: On a Langendorff-type model of rat heart, 10−5 and 10−4 M amifostine alone induced a coronary dilation and, when associated with a cardiotoxic concentration of 2.5 × 10−5 M doxorubicin, 10−5 and 10−4 M amifostine displayed a cardioprotective effect.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 9 March 1998 / Accepted: 6 July 1998
Rights and permissions
About this article
Cite this article
Nazeyrollas, P., Prévost, A., Baccard, N. et al. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity. Cancer Chemother Pharmacol 43, 227–232 (1999). https://doi.org/10.1007/s002800050888
Issue Date:
DOI: https://doi.org/10.1007/s002800050888